The present invention includes a method of reducing or inhibiting the kinaseactivity of normaland mutated FLT3 in a cell or a subject, and the use of such compound forpreventing or treatingcell proliferative disorder(s) in a subject related to using a compound of thepresent invention:(see above formula)or pharmaceutically acceptable salt thereof.